PropThink was an online financial media outlet and intelligence service that provided executive insights, proprietary analysis, and investment commentary on the life science and biotechnology industry. Active primarily between 2011 and 2017, the platform was designed to help investors navigate the high-risk, high-reward world of small-cap biotech stocks by offering in-depth articles, interviews with industry executives, and market analysis. It aimed to deliver institutional-quality research to a broader audience of individual investors.